Literature DB >> 17216266

[Diagnosis and therapy of tumor related pain].

M Kloke1.   

Abstract

The World Health Organization guidelines for cancer pain therapy from 1986 are still valid. A prerequisite for adequate pain palliation is an exact anamnesis and pain diagnosis. A multimodal, staged therapeutic concept then needs to be formulated according to the requirements of the patient. The pharmacological treatment starts with non-opioids. If pain control remains insufficient, weak opioids are added. In case of persistent pain these are replaced by strong opioids. The availability of new opioids and/or preparations admits a more sophisticated approach to metabolic disorders and specific pain syndromes. Depending on the presenting pain type, co-analgesics might be added.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17216266     DOI: 10.1007/s00120-006-1277-2

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  18 in total

1.  Gaps and junctions between clinical experience and theoretical framework in the use of opioids.

Authors:  Marianne Kloke
Journal:  Support Care Cancer       Date:  2004-11       Impact factor: 3.603

2.  Validation of World Health Organization guidelines for cancer pain relief during the last days and hours of life.

Authors:  S Grond; D Zech; S A Schug; J Lynch; K A Lehmann
Journal:  J Pain Symptom Manage       Date:  1991-10       Impact factor: 3.612

3.  A prospective multicenter assessment of the Edmonton staging system for cancer pain.

Authors:  E Bruera; T Schoeller; R Wenk; T MacEachern; S Marcelino; J Hanson; M Suarez-Almazor
Journal:  J Pain Symptom Manage       Date:  1995-07       Impact factor: 3.612

4.  Low morphine doses in opioid-naive cancer patients with pain.

Authors:  Sebastiano Mercadante; Gianpiero Porzio; Patrizia Ferrera; Fabio Fulfaro; Federica Aielli; Corrado Ficorella; Lucilla Verna; Walter Tirelli; Patrizia Villari; Edoardo Arcuri
Journal:  J Pain Symptom Manage       Date:  2006-03       Impact factor: 3.612

5.  EFNS guidelines on pharmacological treatment of neuropathic pain.

Authors:  N Attal; G Cruccu; M Haanpää; P Hansson; T S Jensen; T Nurmikko; C Sampaio; S Sindrup; P Wiffen
Journal:  Eur J Neurol       Date:  2006-11       Impact factor: 6.089

6.  Safety and pain palliation of zoledronic acid in patients with breast cancer, prostate cancer, or multiple myeloma who previously received bisphosphonate therapy.

Authors:  Charles L Vogel; Ronald H Yanagihara; Albert J Wood; Frederick M Schnell; Charles Henderson; Barry H Kaplan; Malcolm H Purdy; Richard Orlowski; Jodi L Decker; Leo Lacerna; John A Hohneker
Journal:  Oncologist       Date:  2004

7.  Rotation to methadone after opioid dose escalation: How should individualization of dosing occur?

Authors:  Camilla Zimmermann; Dori Seccareccia; Christopher M Booth; Wayne Cottrell
Journal:  J Pain Palliat Care Pharmacother       Date:  2005

8.  Bone cancer pain.

Authors:  Denis R Clohisy; Patrick W Mantyh
Journal:  Cancer       Date:  2003-02-01       Impact factor: 6.860

9.  Use of transdermal fentanyl without prior opioid stabilization in patients with cancer pain.

Authors:  Mohamed Omar Tawfik; Vladimir Bryuzgin; Galina Kourteva
Journal:  Curr Med Res Opin       Date:  2004-03       Impact factor: 2.580

10.  [MIDOS--validation of a minimal documentation system for palliative medicine].

Authors:  L Radbruch; R Sabatowski; G Loick; I Jonen-Thielemann; F Elsner; E Hörmann
Journal:  Schmerz       Date:  2000-08       Impact factor: 1.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.